Radiation
Short course radiation
Short course radiation is a radiation therapy with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
RADIATION
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)
Phase Distribution
Ph phase_1
1
33%
Ph phase_2
2
67%
Phase Distribution
1
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Terminated(1)
Other(1)
Detailed Status
Terminated1
unknown1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (33.3%)
Phase 22 (66.7%)
Trials by Status
terminated133%
unknown133%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
terminatedphase_1
A Safety Study Adding Niraparib and Dostarlimab to Radiation Therapy for Rectal Cancers
NCT04926324
recruitingphase_2
MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer
NCT06998342
unknownphase_2
FOLFIRINOX + RT for Pancreatic Cancer
NCT01591733
Clinical Trials (3)
Showing 3 of 3 trials
NCT04926324Phase 1
A Safety Study Adding Niraparib and Dostarlimab to Radiation Therapy for Rectal Cancers
NCT06998342Phase 2
MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer
NCT01591733Phase 2
FOLFIRINOX + RT for Pancreatic Cancer
All 3 trials loaded
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 3